NAD+ IV Therapy: Benefits, Science, and What to Expect

NAD+ — nicotinamide adenine dinucleotide — is present in every cell in your body. It is not a trendy supplement or a marketing abstraction. It is a fundamental coenzyme involved in cellular energy production, DNA repair, and the regulation of proteins that govern aging at the molecular level. After age 40, NAD+ levels decline by approximately 50% — and decades of research now link that decline to the biology of aging. IV therapy delivers NAD+ directly into the bloodstream at full bioavailability, something no oral supplement can replicate. This article explains the science without the hype, and what the BioGenesis protocol looks like in practice.

What Is NAD+?

Nicotinamide adenine dinucleotide is a coenzyme derived from niacin (Vitamin B3). It exists in two primary forms: NAD+ (the oxidized form, which accepts electrons) and NADH (the reduced form, which donates them). This redox cycling is at the center of cellular energy metabolism — specifically the mitochondrial process that converts food into ATP, the energy currency cells use for virtually all biological functions.

Beyond energy metabolism, NAD+ serves two other critical functions that explain its significance to aging:

• DNA repair substrate — NAD+ is consumed by PARP enzymes (poly ADP-ribose polymerases) that detect and repair DNA strand breaks. As DNA damage accumulates with age, PARP activity increases, depleting NAD+ further — creating a compounding deficit.
• Sirtuin activation — Sirtuins are a family of proteins (SIRT1–SIRT7) that regulate gene expression, inflammation, stress response, and metabolic function. Sirtuins are NAD+-dependent — they cannot function without it. Declining NAD+ levels directly impair sirtuin activity, which is one mechanism by which aging is accelerated at the cellular level.

This is why NAD+ occupies a central position in longevity research. It is not one pathway among many — it sits at the intersection of energy metabolism, genetic stability, and the regulation of aging itself.

Why IV Is More Effective Than Oral NAD+ Supplementation

Oral NAD+ supplementation faces a fundamental bioavailability problem. NAD+ taken orally is broken down in the gut before it can be absorbed intact. What actually enters the bloodstream are precursor metabolites — primarily nicotinamide (NAM) — which the body must then reconvert to NAD+ in the liver and other tissues. The efficiency of this conversion varies by individual and declines with age and metabolic health.

Oral NAD+ precursors — NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — bypass some of these limitations by providing molecules that are one or two steps closer to NAD+ in the biosynthetic pathway. Research shows they can raise plasma NAD+ levels. But absorption still varies, the process takes time, and peak plasma levels are modest compared to what IV administration achieves.

IV NAD+ infusion delivers the molecule directly into the bloodstream. Bioavailability is 100%. Peak plasma levels are achieved within the infusion window — not over hours or days of dietary conversion. This is not a marketing distinction. It is a pharmacokinetic difference that translates to a measurably different clinical experience.

What NAD+ IV Therapy Can Do

The clinical evidence and patient-reported outcomes for NAD+ IV therapy are consistent across several domains. These are the areas where the mechanism is well-supported and the patient experience aligns with the biology:

Energy and Stamina

Mitochondria depend on NAD+ to convert nutrients into ATP. When NAD+ is depleted, mitochondrial efficiency drops. Patients with chronic fatigue — whether from aging, metabolic stress, or sustained illness — consistently report improved energy and reduced fatigue following NAD+ infusion series. The mechanism is direct: more NAD+ supports better mitochondrial function.

Cognitive Clarity

The brain is metabolically expensive — neurons require substantial ATP. NAD+ supports not only energy production but also neuroprotective pathways via SIRT1 and SIRT3 activation. Patients report improvements in mental sharpness, focus, and recall. Some research supports NAD+ as neuroprotective in the context of age-related cognitive decline, though clinical data is still accumulating.

Cellular Repair Acceleration

PARP enzymes — the DNA damage repair machinery — consume NAD+ at significant rates when DNA strand breaks are detected. Replenishing NAD+ supports the cell's ability to conduct ongoing DNA maintenance. This is particularly relevant for patients whose DNA repair capacity has declined with age or chronic disease. It also provides a rationale for why NAD+ is considered an anti-aging intervention at the cellular level.

Sleep Quality

NAD+ influences circadian rhythm regulation via SIRT1 activity on clock genes. Patients frequently report improvements in sleep depth and sleep architecture after a NAD+ infusion series. This is consistent with the known biology — circadian disruption is both a cause and consequence of NAD+ decline, and restoring levels can partially restore proper clock gene function.

Athletic Recovery

Exercise-induced oxidative stress and muscle micro-damage require cellular repair processes that are NAD+-dependent. Athletes using NAD+ IV therapy as part of recovery protocols report faster subjective recovery between training sessions. This is one of the more accessible benefits to observe because the timeline between exertion and recovery is concrete and measurable.

What NAD+ IV Therapy Cannot Do

Clarity here matters as much as enthusiasm. NAD+ therapy is a powerful metabolic intervention — it is not a cure for disease, and conflating it with treatments it does not replicate does patients a disservice.

• Not a replacement for sleep. NAD+ supports circadian function but does not substitute for adequate sleep. No infusion compensates for chronic sleep deprivation at a cellular level.
• Not equivalent to stem cell therapy. NAD+ and MSC therapy operate through completely different mechanisms. NAD+ optimizes cellular metabolism. Stem cells introduce new cellular populations that modulate inflammation and tissue repair. They are complementary — not interchangeable.
• Not a cure for chronic disease. NAD+ supports cellular health and repair pathways. It does not reverse structural tissue damage, eliminate autoimmune triggers, or treat the underlying pathology of most chronic conditions in isolation.
• Effects are temporary without maintenance. NAD+ levels naturally decline after infusion. Without dietary support, lifestyle optimization, or ongoing infusion protocols, levels return toward baseline over 4–8 weeks.

The BioGenesis NAD+ Protocol

At BioGenesis, NAD+ infusions are conducted as part of the IV therapy suite and integrated into broader treatment programs. The protocol is individualized based on your baseline, goals, and whether NAD+ is being combined with other interventions.

Dosing and Infusion Duration

NAD+ infusions are typically administered over 2–4 hours. The infusion rate is deliberately controlled — administering NAD+ too quickly produces dose-dependent side effects including flushing, warmth, and nausea. These are physiological responses caused by rapid NAD+ metabolism, not allergic reactions, and they resolve when the rate is reduced. Starting at a conservative rate and titrating up over the session is standard practice.

Standard doses at BioGenesis range from 250mg to 1,000mg depending on individual assessment. First-time patients typically begin at the lower end of this range, with subsequent sessions adjusted based on response and tolerance.

What to Expect During the Infusion

You will be comfortably seated or reclined throughout the session. An IV line is placed, typically in the forearm. At lower doses and controlled rates, most patients experience a mild warm sensation and a subtle sense of heightened alertness during the infusion. At higher doses, flushing, chest pressure, and transient nausea are possible — all of which resolve when the infusion rate is slowed. Medical staff are present throughout to monitor and adjust.

After the infusion, patients are observed briefly before discharge. Most people feel well and can return to normal activities the same day. Some experience a fatigue response in the first 12–24 hours, particularly after higher-dose sessions — this is temporary and followed by the energy improvement the therapy is known for.

Combining NAD+ with Stem Cell Therapy

For patients undergoing MSC stem cell therapy at BioGenesis, NAD+ infusion can be integrated as a preparation or adjunct protocol. The rationale is mechanistic: MSCs exert their effects partly through paracrine signaling — releasing factors that modulate the local cellular environment. That environment is more receptive when baseline cellular energetics are optimized. A cell operating with depleted NAD+ is not in the same metabolic state as one with restored levels.

NAD+ therapy does not replace or duplicate stem cell therapy. Exosome therapy operates on a similar principle — working within the cellular communication network rather than introducing new cells. BioGenesis combination protocols pair these therapies where clinically appropriate, with each element serving a distinct and complementary role in the overall program.

The sequencing and combination of these therapies is determined by Dr. Moreno on a case-by-case basis during the intake evaluation. Not every patient requires every modality. The goal is a protocol designed for your specific condition, biology, and goals — not a standard package applied to everyone.

Frequently Asked Questions

How often should I get NAD+ IV therapy?

For general optimization, most patients begin with a series of 4–6 sessions over two to three weeks, then transition to monthly or quarterly maintenance. Patients combining NAD+ with stem cell therapy follow a coordinated schedule designed by the BioGenesis team. Frequency also depends on symptom response and goals — some patients find quarterly sessions sufficient, others benefit from monthly maintenance.

Is NAD+ IV therapy safe?

NAD+ IV therapy has a strong safety profile when administered at appropriate doses and rates. Common intra-infusion effects at higher doses — flushing, warmth, transient nausea — are normal physiological responses that resolve with rate reduction. Serious adverse events are rare. All BioGenesis infusions are monitored by medical staff throughout the session.

How long does the effect last?

Acute effects — energy, mental clarity — typically appear within 24–48 hours and can persist for 4–8 weeks. NAD+ levels naturally decline without maintenance, which is why ongoing infusion protocols are standard. Lifestyle factors — sleep, diet quality, alcohol intake, stress — significantly affect how long the effect is sustained.

What is the difference between NAD+ and NMN supplements?

NMN and NR are precursor molecules that the body converts into NAD+. Oral supplements using these precursors can raise NAD+ levels and represent a valid lower-cost approach for maintenance. The pharmacokinetic difference from IV is meaningful: precursors require conversion steps that reduce efficiency and predictability. IV NAD+ delivers the molecule directly at full bioavailability. For patients seeking the strongest and most consistent response — particularly when combining with other regenerative therapies — IV is the more effective delivery route.